Skip to main content
. 2022 Apr 7;102(14):e33468. doi: 10.1097/MD.0000000000033468

Figure 1.

Figure 1.

Differential expression of CDKN2A in pan-cancers. (A) mRNA levels of CDKN2A in pan-cancers and their corresponding normal samples performed by TIMER2 database. (B) CDKN2A expression from GEPIA2 database. (C) Correlation analysis of CDKN2A expression and tumor pathological stage. CDKN2A = cyclin dependent kinase inhibitor 2A, GEPIA2 = gene expression profiling interactive analysis.